How should mechanical ventilation be managed in an adult with acute respiratory distress syndrome?

Mechanical Ventilation in ARDS

All adults with ARDS must be ventilated with low tidal volumes of 6 mL/kg predicted body weight (range 4-8 mL/kg) and plateau pressures maintained below 30 cm H₂O. This lung-protective ventilation strategy is the only intervention with high-quality evidence demonstrating mortality reduction and forms the foundation of ARDS management 1, 2.

Core Ventilator Settings (Apply to ALL ARDS patients)

Tidal Volume and Pressure Targets

• Target tidal volume: 6 mL/kg predicted body weight (strong recommendation, high-quality evidence) 1, 2
• Plateau pressure: ≤30 cm H₂O (strong recommendation, moderate-quality evidence) 1, 2
• Calculate predicted body weight using height-based formulas, NOT actual body weight
• If plateau pressure exceeds 30 cm H₂O despite 6 mL/kg, reduce tidal volume further to 4-5 mL/kg 2

PEEP Strategy

Use higher PEEP (typically 10-15 cm H₂O) in moderate to severe ARDS (PaO₂/FiO₂ <200) rather than lower PEEP 1, 3. While this is a conditional recommendation with moderate certainty, higher PEEP prevents atelectotrauma and improves oxygenation. Titrate PEEP based on:

• Oxygenation response
• Hemodynamic tolerance
• Driving pressure (plateau pressure minus PEEP—aim to keep <15 cm H₂O)
• Consider esophageal pressure monitoring for individualized PEEP selection 4

Recruitment Maneuvers

Do NOT use prolonged recruitment maneuvers (strong recommendation against, moderate certainty) 3. Brief recruitment maneuvers may be considered in severe ARDS (weak recommendation), but avoid sustained high-pressure maneuvers that can cause hemodynamic compromise and barotrauma 1.

Severity-Based Interventions

Severe ARDS (PaO₂/FiO₂ <150 mm Hg)

Implement prone positioning for >12 hours daily (strong recommendation, moderate-quality evidence) 1, 2, 3. This is the second intervention with proven mortality benefit in severe ARDS. Start proning early—within 24-48 hours of meeting criteria—and continue daily sessions until oxygenation improves.

Consider neuromuscular blockade for ≤48 hours in early severe ARDS (PaO₂/FiO₂ <150 mm Hg) (conditional recommendation, low certainty) 1, 3. While the 2024 update downgraded this to conditional, it remains an option for patients with severe hypoxemia and ventilator dyssynchrony in the first 48 hours.

Consider corticosteroids (conditional recommendation, moderate certainty) 3. The 2024 guideline update suggests using corticosteroids for ARDS patients, though timing and dosing require clinical judgment.

Consider VV-ECMO in selected patients with very severe ARDS who fail conventional management (conditional recommendation, low certainty) 3. Transfer to an ECMO-capable center should occur early if refractory hypoxemia persists despite maximal conventional therapy.

Moderate ARDS (PaO₂/FiO₂ 100-200 mm Hg)

Apply all core ventilator settings above. Higher PEEP is suggested for moderate ARDS 1, 3. Prone positioning may be considered if oxygenation deteriorates toward severe ARDS thresholds, though the strong recommendation applies specifically to PaO₂/FiO₂ <150.

Mild ARDS (PaO₂/FiO₂ 200-300 mm Hg)

Maintain lung-protective ventilation with low tidal volumes and plateau pressure limits. Higher PEEP is less clearly beneficial in mild ARDS, so use moderate PEEP (8-10 cm H₂O) and titrate based on oxygenation and compliance 4.

What NOT to Do

• Do NOT use high-frequency oscillatory ventilation (strong recommendation against, moderate-quality evidence) 1, 2—it increases mortality
• Do NOT use β-2 agonists routinely (strong recommendation against) 1—no benefit and possible harm
• Do NOT use pulmonary artery catheters routinely (strong recommendation against, high-quality evidence) 1
• Do NOT use high tidal volumes (>8 mL/kg)—this causes ventilator-induced lung injury and increases mortality

Fluid Management

Use a conservative fluid strategy once ARDS is established and tissue perfusion is adequate (strong recommendation, moderate-quality evidence) 1. Restrict fluids to maintain neutral to negative fluid balance, which improves oxygenation and reduces ventilator days. However, ensure adequate perfusion first—do not restrict fluids in patients with shock or tissue hypoperfusion.

Supportive Care

• Elevate head of bed 30-45 degrees to prevent aspiration and ventilator-associated pneumonia (strong recommendation) 1
• Minimize sedation to facilitate spontaneous breathing trials once the acute phase resolves 1
• Use spontaneous breathing trials and weaning protocols when patients meet readiness criteria (strong recommendation, high-quality evidence) 1

Common Pitfalls

1. Failing to calculate predicted body weight correctly—using actual weight leads to excessive tidal volumes in obese patients
2. Not measuring plateau pressure—you cannot implement lung-protective ventilation without knowing plateau pressure
3. Delaying prone positioning—waiting too long reduces its effectiveness; start within 24-48 hours of meeting criteria
4. Using recruitment maneuvers too aggressively—prolonged high-pressure maneuvers cause harm
5. Liberal fluid administration—worsens pulmonary edema and prolongs mechanical ventilation once ARDS is established

Clinical Algorithm

1. Confirm ARDS diagnosis (bilateral infiltrates, PaO₂/FiO₂ ≤300, within 1 week of known insult, not fully explained by heart failure)
2. Immediately implement lung-protective ventilation: 6 mL/kg PBW, plateau pressure <30 cm H₂O
3. Classify severity by PaO₂/FiO₂ ratio
4. **If PaO₂/FiO₂ <150**: Start prone positioning >12 hours daily + consider neuromuscular blockade for 48 hours + consider corticosteroids
5. If moderate-severe ARDS: Use higher PEEP (10-15 cm H₂O)
6. If refractory hypoxemia despite maximal therapy: Consider VV-ECMO at experienced center
7. Once stabilized: Conservative fluid management, minimize sedation, daily spontaneous breathing trials

The evidence strongly supports this algorithmic approach, with lung-protective ventilation and prone positioning in severe ARDS being the only interventions with definitive mortality benefit 1, 2, 3.